BTT vs KARD Comparison

Blackrock Municipal 2030 Target Term Trust is a United States-based fixed-term, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and to return $25.00 per common share to common shareholders at maturity. The Fund invests the majority of its managed assets in investment-grade municipal securities, the interest of which is exempt from regular federal income tax, and derivatives that provide investment exposure to such securities or to one or more market risk factors associated with such securities.

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.